Mold Illness and CIRS: The Complete Guide to Diagnosis, Treatment, and Recovery

What Is Mold Illness? Understanding CIRS

Mold illness is the informal term for what researchers and clinicians call Chronic Inflammatory Response Syndrome (CIRS). It was first characterized by Dr. Ritchie Shoemaker, a physician who spent decades studying patients exposed to biotoxins in water-damaged buildings [1].

CIRS is not an allergy. It is not a simple reaction to mold spores floating through the air. It is a chronic, systemic inflammatory response that occurs when genetically susceptible individuals are exposed to biotoxins produced by certain molds, bacteria, and actinomycetes that thrive in water-damaged environments.

The biotoxins involved are small enough to pass through cell membranes but large enough to avoid being processed by the adaptive immune system in susceptible people. The result is a runaway innate immune response that does not shut off on its own, even after the person leaves the moldy environment [2].

Think of it this way: in a healthy person with the right genetics, the immune system tags the biotoxin, processes it, and eliminates it. In someone with CIRS-susceptible genes, the toxin circulates indefinitely, triggering wave after wave of inflammation across multiple organ systems.

The Genetic Link: HLA-DR and Why Some People Get Sick

One of the most important discoveries in mold illness research is the role of Human Leukocyte Antigen (HLA-DR) genes. These genes code for proteins on the surface of immune cells that help present foreign substances to the adaptive immune system.

Approximately 24-25% of the general population carries HLA-DR haplotypes that make them poor biotoxin clearers [3]. Within that group, about 2% carry what Shoemaker calls the “dreaded genotype” (multisusceptible 4-3-53), which makes them reactive to virtually every category of biotoxin.

This explains a pattern that doctors and patients encounter constantly: an entire family lives in a water-damaged home, but only one or two members become severely ill. The rest may have mild symptoms or none at all. It is not that the sick person is imagining things. Their immune system is literally wired differently.

HLA-DR testing is done through a simple blood draw and is available through most commercial labs (LabCorp test code 012542, for example). Knowing your HLA type does not change treatment, but it confirms susceptibility and helps explain why standard approaches have not worked.

Where Mold Exposure Happens

When most people think of mold, they picture a black-spotted shower curtain or visible growth in a basement. But the mold that drives CIRS is often hidden. It grows inside wall cavities, above ceiling tiles, beneath flooring, around HVAC systems, and in any area where moisture has been trapped.

Water-Damaged Buildings

The primary source of CIRS-triggering biotoxins is water-damaged buildings (WDBs). Studies estimate that 50% of buildings in the United States have some history of water damage [4]. Not every water-damaged building will make someone sick, but the combination of specific mold species, bacterial endotoxins, and volatile organic compounds creates a toxic soup that overwhelms susceptible immune systems.

Common scenarios include:

• Homes with past flooding, roof leaks, or plumbing failures
• Buildings with poor ventilation or HVAC condensation issues
• Basements and crawl spaces with chronic moisture
• Schools and office buildings with deferred maintenance
• New construction with building envelope failures that trap moisture

Workplace Exposure

Many CIRS patients trace their illness to a workplace. Schools are particularly common culprits, as are older office buildings, hospitals, and any commercial structure where water intrusion has been patched over rather than properly remediated. Employees may notice they feel better on weekends and vacations, only to relapse when they return to work.

Home Exposure

Home exposure is often the most damaging because of the sheer number of hours spent there. A small, hidden leak behind a bathroom wall can produce enough biotoxins to keep the inflammatory cascade running indefinitely in a susceptible person. The challenge is that you can have a serious mold problem with zero visible signs and zero musty odor.

Symptoms of Mold Illness: A Multi-System Problem

One reason CIRS is so frequently misdiagnosed is that it affects nearly every organ system in the body. Patients often see a dozen specialists before getting an accurate diagnosis, collecting labels like fibromyalgia, chronic fatigue syndrome, depression, anxiety, and irritable bowel syndrome along the way.

Common symptoms include:

Neurological and Cognitive

• Brain fog and poor concentration
• Memory problems (especially short-term)
• Word-finding difficulty
• Disorientation and confusion
• Light sensitivity (photophobia)
• Headaches
• Numbness and tingling
• Static shocks (an unusual but characteristic symptom)

Musculoskeletal

• Joint pain without swelling
• Muscle cramps and aches
• Morning stiffness
• Ice-pick or sharp pains

Respiratory and Sinus

• Chronic sinus congestion
• Shortness of breath
• Cough
• Air hunger

Systemic

• Crushing fatigue that does not improve with rest
• Night sweats
• Temperature dysregulation
• Metallic taste in the mouth
• Increased thirst and frequent urination
• Appetite changes and weight gain (or loss)
• Mood swings, anxiety, and depression
• Skin rashes and unusual bruising

Shoemaker’s research identified 37 symptoms clustered into 13 categories. Having symptoms in 8 or more clusters is strongly suggestive of CIRS [5]. The hallmark is the multi-system nature of the complaints. If a patient presents with fatigue, brain fog, joint pain, sinus issues, and shortness of breath all at the same time, and standard workups keep coming back normal, CIRS should be on the differential.

How CIRS Is Diagnosed

There is no single test that confirms CIRS. Diagnosis is built on a combination of clinical history, objective testing, and environmental assessment.

Visual Contrast Sensitivity (VCS) Test

The VCS test measures your ability to distinguish between shades of gray at different spatial frequencies. Biotoxins affect the optic nerve and visual processing pathways, and studies show that 92% of CIRS patients fail the VCS test [6]. It is a simple, inexpensive screening tool available online (survivingmold.com offers a validated version) or in a clinician’s office. A passing VCS does not rule out CIRS, but a failing VCS in the context of compatible symptoms is a strong signal.

Bloodwork: The Biotoxin Panel

Shoemaker identified a panel of biomarkers that are characteristically abnormal in CIRS. These markers reflect the downstream effects of chronic innate immune activation:

• MSH (Melanocyte-Stimulating Hormone): Usually low. MSH is a master regulatory hormone that controls inflammation, mood, sleep, and pain perception. Low MSH is found in over 95% of CIRS patients [7].
• VIP (Vasoactive Intestinal Peptide): Usually low. VIP regulates blood flow, inflammation in the lungs and brain, and gut function.
• MMP-9 (Matrix Metalloproteinase-9): Usually elevated. MMP-9 is a tissue-destroying enzyme released during inflammation. It drives much of the joint pain, brain fog, and tissue damage seen in CIRS [8].
• TGF-beta1 (Transforming Growth Factor Beta-1): Usually elevated. This cytokine is involved in fibrosis, autoimmunity, and immune dysregulation.
• C4a: Usually elevated. C4a is a complement split product that reflects innate immune activation. It is one of the most sensitive markers for ongoing biotoxin exposure.
• VEGF (Vascular Endothelial Growth Factor): Can be high or low, but is often dysregulated. VEGF controls blood vessel formation and tissue oxygenation.
• ADH and Osmolality: ADH (antidiuretic hormone) is often dysregulated, leading to abnormal thirst, frequent urination, and dehydration despite adequate water intake.
• Leptin: Often elevated, contributing to weight gain resistance and hormonal disruption.

No single marker is diagnostic on its own. The pattern of abnormalities across multiple markers is what confirms CIRS.

Environmental Testing: ERMI and HERTSMI-2

The Environmental Relative Moldiness Index (ERMI) was developed by the EPA to quantify mold burden in buildings using DNA-based analysis of dust samples [9]. It tests for 36 mold species and produces a score that indicates relative moldiness.

The HERTSMI-2 is a simplified version that focuses on the five mold species most associated with water damage and CIRS: Aspergillus penicillioides, Aspergillus versicolor, Chaetomium globosum, Stachybotrys chartarum, and Wallemia sebi. A HERTSMI-2 score above 10 is considered unsafe for CIRS patients.

These tests are done by collecting a dust sample from the home or workplace and sending it to a lab like Mycometrics or EnviroBiomics. Testing costs roughly $150-300 per sample.

The Shoemaker Protocol: Step-by-Step Treatment

Dr. Shoemaker developed a sequential treatment protocol based on decades of clinical experience and published research. Each step must be completed before moving to the next, because the steps build on each other [10].

Step 1: Remove from Exposure

Nothing else works if the patient is still being exposed to biotoxins. This is the hardest step for many people because it may mean leaving a home, changing jobs, or spending significant money on remediation. But it is non-negotiable. Trying to treat CIRS while continuing to live or work in a water-damaged building is like trying to heal a burn while keeping your hand on the stove.

Step 2: Cholestyramine or Welchol (Binders)

Cholestyramine (CSM) is a bile acid sequestrant that binds biotoxins in the gut and prevents them from being reabsorbed through enterohepatic recirculation. The standard dose is 4 grams taken four times daily, away from food and other medications. Welchol (colesevelam) is an alternative for patients who cannot tolerate CSM, though it is considered less potent [11].

Binder therapy typically continues for one to three months, guided by repeat VCS testing and symptom tracking. Many patients notice significant improvement in brain fog, fatigue, and pain during this phase.

Step 3: Eradicate MARCoNS

MARCoNS (Multiple Antibiotic Resistant Coagulase Negative Staphylococci) are antibiotic-resistant biofilm-forming bacteria that colonize the nasal passages in many CIRS patients, particularly those with low MSH. MARCoNS are detected through a deep nasal swab culture (API-Staph test). Treatment involves BEG spray (Bactroban, EDTA, and Gentamicin compounded nasal spray) used for 30 days [12].

Step 4: Correct Androgens

CIRS commonly suppresses androgens including DHEA and testosterone. Once MARCoNS are cleared and MSH begins to recover, androgen levels may normalize on their own. If not, careful supplementation may be needed.

Step 5: Correct ADH and Osmolality

If ADH remains dysregulated after the earlier steps, treatment with DDAVP (desmopressin) may be needed to restore normal fluid balance.

Step 6: Correct MMP-9

Elevated MMP-9 often responds to a combination of low-amylose diet (avoiding simple carbohydrates and grains) and fish oil supplementation. High-dose omega-3 fatty acids at 2.4 grams EPA/DHA daily have shown benefit.

Step 7: Correct VEGF

Low VEGF leads to poor tissue oxygenation, exercise intolerance, and fatigue. Treatment typically involves high-dose omega-3 fatty acids if not already started, along with correcting upstream markers.

Step 8: Correct C3a and C4a

Persistent elevation of complement markers suggests ongoing immune activation. High-dose fish oil, statin therapy (for C4a), and ensuring complete removal from exposure are the primary strategies.

Step 9: VIP Nasal Spray

Vasoactive Intestinal Peptide (VIP) nasal spray is the final step in the protocol, reserved for patients who have completed all prior steps and have a HERTSMI-2 score below 10 in their home. VIP is a regulatory neuropeptide that helps restore immune balance, improve pulmonary function, and normalize many of the biomarkers disrupted by CIRS [13]. It is available through compounding pharmacies.

Integrating Other Approaches with the Shoemaker Protocol

While the Shoemaker Protocol forms the clinical backbone of CIRS treatment, many practitioners and patients find benefit from additional supportive therapies.

Glutathione Support

Glutathione is the body’s master antioxidant and plays a critical role in Phase II liver detoxification. CIRS patients often have depleted glutathione levels. Liposomal glutathione (400-800 mg daily), NAC (N-acetylcysteine, 600-1200 mg daily), or IV glutathione may support the detoxification process. Some patients are sensitive to glutathione and should start with very low doses [14].

NAD+ Therapy

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in cellular energy production and DNA repair. Biotoxin exposure appears to deplete NAD+ levels, and supplementation through oral NMN, NR, or IV NAD+ infusions may support mitochondrial recovery and reduce fatigue. Clinical data in CIRS populations is limited, but the biochemical rationale is sound.

Sauna Detoxification

Infrared sauna therapy may support biotoxin elimination through sweat. Studies on firefighters and other toxin-exposed populations have shown that sauna protocols can reduce body burden of certain chemicals [15]. For CIRS patients, low-and-slow protocols (starting at 15-20 minutes, 130-140F) are generally better tolerated than aggressive high-heat sessions. Adequate mineral and electrolyte replacement is essential.

Mold-Free Diet

A low-mold diet removes foods that commonly contain mycotoxins or promote inflammation: dried fruits, aged cheeses, conventional coffee, peanuts, corn, wheat, alcohol (especially beer and wine), and leftovers stored for more than 24 hours. While no controlled trials have tested a “mold-free diet” specifically for CIRS, reducing dietary mycotoxin exposure is a reasonable precaution during active treatment.

Air Purification

HEPA air purifiers with activated carbon filters can reduce airborne mold spore counts and volatile organic compounds. Units should be rated for the room size and run continuously. IQAir, Austin Air, and Intellipure are commonly recommended brands in the mold illness community. Air purification is a supportive measure, not a substitute for proper remediation.

Mold Allergy vs. Mold Illness (CIRS): What Is the Difference?

This distinction matters because the treatments are entirely different.

Mold allergy is an IgE-mediated immune response to mold spores. It causes typical allergy symptoms: sneezing, runny nose, watery eyes, and sometimes asthma. It responds to antihistamines, nasal steroids, and allergy immunotherapy. Standard allergy testing (skin prick or IgE blood panels) can confirm it.

Mold illness (CIRS) is an innate immune response to biotoxins that does not involve IgE antibodies. Standard allergy tests will be negative. Antihistamines do not help. The symptoms are systemic and involve far more than the respiratory tract. A person can have both mold allergy and CIRS simultaneously, which can complicate the picture.

If a doctor tells you “your mold allergy tests are negative, so mold isn’t your problem,” they may be looking at the wrong immune pathway entirely.

Environmental Remediation Basics

If testing confirms that your home or workplace has a mold problem, remediation is necessary. Here are the fundamentals:

• Identify and fix the moisture source first. Removing visible mold without addressing the water intrusion is pointless. The mold will return.
• Hire a qualified remediator. Look for IICRC (Institute of Inspection Cleaning and Restoration Certification) or ACAC (American Council for Accredited Certification) credentials. The person doing the testing should not be the same company doing the remediation to avoid conflicts of interest.
• Containment is critical. Proper remediation involves setting up negative air pressure containment to prevent cross-contamination of clean areas during removal.
• Porous materials usually need to go. Drywall, carpet, insulation, and other porous materials that have been colonized by mold generally cannot be cleaned and must be removed and replaced.
• Post-remediation verification testing (ERMI or HERTSMI-2 and air clearance testing) should be done before a CIRS patient moves back in.
• HVAC cleaning is often necessary, as mold spores travel through ductwork and colonize the system.

Remediation costs vary enormously depending on the scope of the problem, from a few thousand dollars for a contained area to tens of thousands for extensive damage. It is a significant investment, but it is the foundation upon which recovery is built.

Finding the Right Doctor

Not every physician is trained to diagnose and treat CIRS. In fact, most are not. Here is what to look for:

• Shoemaker-certified practitioners have completed training through Dr. Shoemaker’s program and follow the published protocol. A list is available at survivingmold.com.
• Mold-literate doctors may not be formally Shoemaker-certified but have clinical experience with CIRS, understand the biomarker panel, and follow evidence-based approaches to biotoxin illness.
• Functional medicine practitioners who have training in environmental medicine and biotoxin illness can be good options, especially if they combine the Shoemaker framework with supportive integrative approaches.

Red flags to watch for: doctors who dismiss mold illness as “not real,” practitioners who recommend only supplements without addressing environmental exposure, or anyone who suggests you can treat CIRS without leaving a contaminated building.

A good CIRS doctor will take a thorough exposure history, order the full biotoxin panel, recommend environmental testing, and follow a systematic treatment approach. They will also track your biomarkers over time to confirm that treatment is working.

Living with CIRS: What Recovery Looks Like

Recovery from CIRS is possible, but it rarely happens overnight. Most patients experience a gradual improvement over months to a year or more, depending on how long they were exposed, their genetic susceptibility, and how thoroughly they address the environmental source.

Some patients recover completely and return to full health. Others achieve significant improvement but remain sensitive to re-exposure and need to be vigilant about their environments long-term. The key factors that predict better outcomes include early diagnosis, complete removal from exposure, and consistent adherence to the treatment protocol.

The emotional toll of CIRS is real. Many patients have been told their symptoms are psychosomatic, that they are anxious or depressed, or that nothing is wrong with them. Finding a diagnosis and a treatment plan that actually addresses the root cause can be profoundly validating. If you suspect mold illness, trust your instincts, get tested, and find a clinician who takes this condition seriously.

Related Reading

• Brain Fog: Causes, Evaluation, and Evidence-Based Solutions
• NAD+ Therapy: What the Science Says
• Evidence-Based Detox Protocols
• Functional Medicine Lab Testing Guide

Frequently Asked Questions

Is mold illness (CIRS) an allergy?

No. According to this guide, CIRS (Chronic Inflammatory Response Syndrome) is not an allergy but a chronic, systemic inflammatory response that occurs when genetically susceptible individuals are exposed to biotoxins, most commonly from water-damaged buildings. It was first characterized by Dr. Ritchie Shoemaker. A person can have both a mold allergy and CIRS at the same time, which can complicate the picture.

Who is at risk of developing CIRS?

The guide states that approximately 24 to 25 percent of the general population carries HLA-DR haplotypes that make them poor biotoxin clearers, and about 2 percent carry what Shoemaker calls the “dreaded genotype” (multisusceptible 4-3-53). This genetic factor explains why an entire family can live in a water-damaged home but only one or two members become severely ill. The page also notes that roughly 50 percent of buildings in the United States have some history of water damage.

How is mold illness diagnosed?

The page describes a combination of a screening test, blood biomarkers, and environmental testing. The Visual Contrast Sensitivity (VCS) test is a common screen, and the guide reports that 92 percent of CIRS patients fail it. Blood work looks at markers such as MSH (low in over 95 percent of CIRS patients), VIP, MMP-9, TGF-beta1, and C4a, while HLA-DR genetic testing is done via a simple blood draw. Shoemaker’s framework counts 37 symptoms across 13 categories, with symptoms in 8 or more clusters considered strongly suggestive of CIRS.

What does treatment involve and how long does it take?

The guide outlines the nine-step Shoemaker Protocol, which begins with removing the person from exposure since nothing else works while exposure continues. Binder therapy with cholestyramine or Welchol (standard dose 4 grams four times daily, away from food and other medications) typically continues for one to three months, guided by repeat VCS testing. Other steps address MARCoNS (a 30-day BEG nasal spray), hormone and immune markers, and end with VIP nasal spray. Most patients experience gradual improvement over months to a year or more, depending on how long they were exposed.

How much does mold testing and remediation cost?

The page says environmental testing such as ERMI and HERTSMI-2 costs roughly $150 to $300 per sample. Remediation costs vary widely, from a few thousand dollars for a contained area to tens of thousands for extensive damage. The guide notes that a HERTSMI-2 score above 10 is considered unsafe for CIRS patients.

Are the supportive therapies safe, and how strong is the evidence?

The guide flags specific cautions: some patients are sensitive to glutathione and should start with very low doses, adequate mineral and electrolyte replacement is essential when using a sauna, and air purification is a supportive measure rather than a substitute for proper remediation. It also hedges on evidence in places, noting that clinical data for NAD+ therapy in CIRS populations is limited even though the biochemical rationale is sound, and that no controlled trials have tested a “mold-free diet” specifically, framing it as a reasonable precaution.

References

1. Shoemaker RC, House DE. A time-series study of sick building syndrome: chronic, biotoxin-associated illness from exposure to water-damaged buildings. Neurotoxicol Teratol. 2004;26(1):29-37. doi:10.1016/j.ntt.2003.07.004
2. Shoemaker RC, House DE, Ryan JC. Structural brain abnormalities in patients with inflammatory illness acquired following exposure to water-damaged buildings. Neurotoxicol Teratol. 2014;45:18-26. doi:10.1016/j.ntt.2014.06.007
3. Shoemaker RC, Hudnell HK. Possible estuary-associated syndrome: symptoms, vision, and treatment. Environ Health Perspect. 2001;109(5):539-545. doi:10.1289/ehp.01109539
4. Mudarri D, Fisk WJ. Public health and economic impact of dampness and mold. Indoor Air. 2007;17(3):226-235. doi:10.1111/j.1600-0668.2007.00474.x
5. Shoemaker RC, Rash J, Simon E. Sick Building Syndrome in water-damaged buildings: generalization of the chronic biotoxin-associated illness paradigm to indoor toxigenic fungi. Bioaerosols, Fungi, Bacteria, Mycotoxins and Human Health. 2006. doi:10.1016/j.ntt.2005.04.004
6. Shoemaker RC, Hudnell HK, House DE, Van Kempen A, Pakes GE. Atovaquone plus cholestyramine in patients sickened by exposure to Pfiesteria species. Environ Health Perspect. 2001. doi:10.1289/ehp.01109539
7. Shoemaker RC, House DE. Sick building syndrome (SBS) and exposure to water-damaged buildings. Neurotoxicol Teratol. 2006;28(5):573-588. doi:10.1016/j.ntt.2006.07.003
8. Shoemaker RC, Maizel MS. Exposure to interior environments of water-damaged buildings causes a CFS-like illness in pediatric patients. Bull IACFS/ME. 2009;17(2):69-74.
9. Vesper S, McKinstry C, Haugland R, et al. Development of an environmental relative moldiness index for US homes. J Occup Environ Med. 2007;49(8):829-833. doi:10.1097/JOM.0b013e3181255e98
10. Shoemaker RC. Residential and recreational acquisition of possible estuary-associated syndrome. Environ Health Perspect. 2001;109 Suppl 5:791-796. doi:10.1289/ehp.01109s5791
11. Shoemaker RC, Dennis S. Cholestyramine as primary treatment for chronic illness acquired following exposure to water-damaged buildings. Expert Opin Pharmacother. 2005;6(8):1255-1260.
12. Brewer JH, Thrasher JD, Straus DC, Madison RA, Hooper D. Detection of mycotoxins in patients with chronic fatigue syndrome. Toxins. 2013;5(4):605-617. doi:10.3390/toxins5040605
13. Shoemaker RC, House D, Ryan JC. Vasoactive intestinal polypeptide (VIP) corrects chronic inflammatory response syndrome (CIRS) acquired following exposure to water-damaged buildings. Health. 2013;5(3):396-401. doi:10.4236/health.2013.53053
14. Pizzorno J. Glutathione! Integr Med (Encinitas). 2014;13(1):8-12. PMID: 26770075.
15. Genuis SJ, Birkholz D, Rodushkin I, Beesoon S. Blood, urine, and sweat (BUS) study: monitoring and elimination of bioaccumulated toxic elements. Arch Environ Contam Toxicol. 2011;61(2):344-357. doi:10.1007/s00244-010-9611-5
16. World Health Organization. WHO Guidelines for Indoor Air Quality: Dampness and Mould. Copenhagen: WHO Regional Office for Europe; 2009.